Lufeng Zheng

19PUBLICATIONS
27CO-AUTHORS
Molecular targetsSolid tumoursEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 02, 2026
Targeting breast cancer stem cells by restoring RBM38 function: mechanism and protein delivery therapy.

|Jul 02, 2026
ISGylation-mediated stabilization of CYP4Z1 fuels breast cancer initiation and progression.

|Apr 08, 2026
Spatial multiomics profiling reveals ZFP36-mediated immunometabolic reprogramming in bladder cancer.

Fangdie Ye, Xuedan Han, Weijian Li

|Feb 25, 2026
Discovery of a Novel Dual-Targeting KRASG12D/HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer.

Qiaoxuan Zhang, Yifei Geng, Haitao Chen

|Jan 22, 2026
Exploration of the mechanism of anlotinib in reversing PD-1 immunotherapy resistance: insights from single-cell sequencing.

Wanjin Shi, Yidong Zhang, Qiyi Yu

|Jan 12, 2026
Fluvastatin suppresses breast cancer initiation and progression via targeting CYP4Z1.

Huilong Li, Ying Chen, Wanjin Shi

Pageof 4

Frequent Collaborators

4 joint publications

Miaomiao Niu

2 joint publications

Xiaoman Li

2 joint publications

Hong Yao

2 joint publications

Jun Yin